KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Consolidated Net Income (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Consolidated Net Income for 16 consecutive years, with $7.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 37.28% to $7.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.5 million, a 166.1% increase, with the full-year FY2025 number at $7.5 million, up 166.1% from a year prior.
  • Consolidated Net Income was $7.5 million for Q4 2025 at Biolife Solutions, down from $12.0 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $12.0 million in Q4 2024 to a low of -$91.9 billion in Q4 2022.
  • A 5-year average of -$5.4 billion and a median of -$7.4 million in 2022 define the central range for Consolidated Net Income.
  • Peak YoY movement for Consolidated Net Income: soared 148.08% in 2021, then plummeted 583609.74% in 2022.
  • Biolife Solutions' Consolidated Net Income stood at -$15.7 million in 2021, then tumbled by 583609.74% to -$91.9 billion in 2022, then surged by 99.96% to -$32.8 million in 2023, then soared by 136.58% to $12.0 million in 2024, then crashed by 37.28% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Consolidated Net Income are $7.5 million (Q4 2025), $12.0 million (Q4 2024), and -$1.2 million (Q3 2024).